Drug
NYX-2925 clinical trials
Also written NYX-2925.
- studies test it
- 4
- open now
- 0
- in phase 3
- 0
- first study started
- 2017
How studies write it
Studies that test it under each name
Development codes
Studies by the year they started
4 studies that test it; most in 2017 (2)
| Year | Studies |
|---|---|
| 2017 | 2 |
| 2019 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 4
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 0
Aptinyx (4)
Studies
Open first, then newest update. How each study uses NYX-2925 is read from its arms, and is right about nine times in ten.
Testing it · 4
- Efficacy and Safety of NYX-2925 in Subjects With FibromyalgiaCompletedPhase 2AptinyxNCT04147858Written as NYX-2925
- Efficacy and Safety of NYX-2925 in Subjects With Neuropathic Pain Associated With Diabetic Peripheral Neuropathy (DPN)CompletedPhase 2AptinyxNCT04146896Written as NYX-2925 50 mg
- Evaluate the Efficacy and Safety of NYX-2925 in Subjects With FibromyalgiaCompletedPhase 2AptinyxNCT03249103Written as NYX-2925
- Efficacy and Safety of NYX-2925 in Subjects With Neuropathic Pain Associated With Diabetic Peripheral NeuropathyCompletedPhase 2AptinyxNCT03219320Written as NYX-2925